Helicobacter pylori and the gastroduodenal mucosa

Surgery

Volumn 130, Issue 1, 2001, Pages 13-16

  Kokoska, Evan R ^a,b   Kauffman Jr , Gordon L ^a,b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; STOMACH SECRETION INHIBITOR;

AUTOIMMUNITY; BACTERIAL COLONIZATION; CELL DAMAGE; DIAGNOSTIC APPROACH ROUTE; GASTROINTESTINAL MUCOSA; HELICOBACTER PYLORI; HUMAN; PEPTIC ULCER; PRIORITY JOURNAL; REVIEW; STOMACH ACID SECRETION; STOMACH CANCER;

EID: 0034931617     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2001.112002     Document Type: Article

References (13)

1. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration
2. How is Helicobacter pylori transmitted
3. Helicobacter pylori factors associated with disease development
4. How does Helicobacter pylori cause mucosal damage? The inflammatory response
5. How does Helicobacter pylori cause mucosal damage? Direct mechanisms
6. Tyrosine-phosphorylated bacterial proteins: Trojan horses for the host cell
7. How does Helicobacter pylori cause mucosal damage? Its effect on acid and gastrin physiology
8. Management of peptic ulcers: Emerging issues
9. Current status of indications for surgery in peptic ulcer disease
10. Trends in peptic ulcer bleeding and surgical treatment
11. What role does Helicobacter pylori play in gastric cancer?
12. Helicobacter pylori, inflammation, mucosal damage, and apoptosis: Pathogenesis and definition of gastric atrophy
13. What role does Helicobacter pylori eradication play in gastric MALT and gastric MALT lymphoma?